Global Pertussis Treatment Market: Key Players, Vaccines, and Market Forecast

Pertussis Market Overview: Trends, Therapies, and Growth Opportunities

The Pertussis Market is poised for steady growth, driven by increasing awareness of whooping cough and the development of more effective interventions. Key players in the market, such as Serum Institute of India, LG Chem, ILiAD Biotechnologies, Dynavax Technologies, Tianjin CanSino Biotechnology, Faron Pharmaceuticals, Kymab, BioNet, and others, are actively contributing to the expansion of the Pertussis Therapeutics Market. With innovative vaccines and emerging therapies, the Pertussis Drugs Market offers substantial growth potential globally.

Market Insights and Scope

According to DelveInsight’s report, “Pertussis Market Insights, Epidemiology, and Market Forecast – 2034”, the study provides a comprehensive analysis of the Pertussis Treatment Market. The research covers historical and projected epidemiology, treatment patterns, emerging therapies, and market dynamics across the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan. Spanning 2020–2034, with forecasts from 2024–2034, the report offers detailed insights into Pertussis Market Size, segmentation by therapy and class, and competitive landscape intelligence.

Understanding Pertussis

Pertussis, or whooping cough, is a severe respiratory infection caused by Bordetella pertussis. The disease progresses in three stages: catarrhal, paroxysmal, and convalescent. Accurate diagnosis is essential and can be achieved through culture, PCR, paired sera, and single sera tests, with paired sera tests considered the most reliable.

Prevention and Treatment

Vaccination remains the cornerstone of Pertussis Therapeutics Market strategies. In the U.S., DTaP and Tdap vaccines are widely administered, with all adolescents and adults recommended to receive at least three doses. Treatment primarily involves macrolide antibiotics, including erythromycin, clarithromycin, and azithromycin, while supportive care such as oxygen therapy, hydration, and avoiding respiratory irritants is essential for patient recovery.

Epidemiology

The report provides historical and forecasted data across the seven major markets (7MM). In 2022, approximately 19 million individuals were vaccinated in the U.S., with 5 million adults receiving booster doses. Across the 7MM, around 34 million people were vaccinated in 2022. Numbers are expected to rise due to greater awareness, updated immunization guidelines, and the introduction of novel vaccines.

Vaccine Landscape

  • ADACEL (Sanofi Pasteur): Trivalent booster for pertussis, tetanus, and diphtheria, available in 55 countries.

  • BOOSTRIX (GSK): Recommended for individuals aged 10+, including maternal immunization programs.

  • Emerging Vaccines:

    • BPZE1 (ILiAD Biotechnologies): Intranasal booster in Phase IIb with FDA Fast Track designation.

    • BK1310/MT-2355 (Mitsubishi Tanabe Pharma): A 5-in-1 combination vaccine planned for Japan.

Market Outlook

Complete immunization is key to controlling pertussis. While infant and childhood vaccination rates are high in the 7MM, adult booster compliance remains relatively low. The Pertussis Treatment Market is competitive in the U.S. and Europe, driven by vaccines such as PEDIARIX, PENTACEL, and Vaxelis, while Mitsubishi dominates Japan with TETRABIK. The total Pertussis Market Size in the 7MM was $3.5 billion in 2022, with the U.S. contributing the largest share.

Vaccine Uptake, Pipeline, and Competitive Insights

The report evaluates adoption rates for recently launched and upcoming vaccines, patient uptake trends, sales performance, and market share. It also explores pipeline development, collaborations, patent filings, and regulatory progress. Reimbursement scenarios highlight economically attractive markets and potential challenges. Additionally, insights from key opinion leaders validate current and emerging treatments, market trends, and unmet needs.

By analyzing the Pertussis Drugs Market, stakeholders gain actionable intelligence on the competitive landscape, market entry strategies, and growth opportunities. The combination of emerging therapies, strong pipeline development, and increasing awareness ensures a promising future for the Pertussis Therapeutics Market globally.
Latest Reports
Acute Pyelonephritis Market | Asperger Syndrome Market | Attention Deficit Hyperactivity Disorder Adhd Market | Cardiopulmonary Management Device Market | Childhood Atropine For Myopia Progression Market | Cholangiocarcinoma Market | Dyspepsia Market | Emphysema Market | Genital Herpes Market | Growth Hormone Deficiency Market | Guillain-barré Syndrome Market | Hairy Cell Leukemia Market | Intestinal Obstruction Market | Malignant Fibrous Histiocytoma Market | Menopause Market | Metabolic Acidosis Market | Multiple Myeloma Market | Neurostimulation Devices Market